Tenax Therapeutics market cap TENX

Share price times shares outstanding: what the whole company sells for, since 2011.

Tenax Therapeutics is worth $64.4M at the close on Oct 23, 2026, at $1.72 a share.

That is up 91% over the last year and up 68% over five years.

Its highest close in our data was $512.7M in Jul 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$64.4M	$50.9M	$512.7M	−19%
2025	$79.1M	$20.4M	$81.8M	+268%
2024	$21.5M	$1.1M	$21.5M	+228%
2023	$6.6M	$1.2M	$10.4M	+32%
2022	$5M	$2.4M	$21.7M	−81%
2021	$26.2M	$22.2M	$45.4M	+12%
2020	$23.5M	$3.4M	$23.5M	+175%
2019	$8.5M	$1.7M	$11.8M	+390%
2018	$1.7M	$1.7M	$13.3M	−87%
2017	$13.8M	$9.3M	$70.3M	−75%
2016	$54.8M	$39.9M	$84.4M	−41%
2015	$92.2M	$84.6M	$106.9M	−12%
2014	$104.9M	$28.8M	$121.1M	+104%
2013	$51.4M	$2.6M	$51.4M	+128%
2012	$22.5M	$16.8M	$74.9M	−34%
2011	$34.1M	$34.1M	$58.5M	n/a

Companies in Drug Manufacturers - General nearest Tenax Therapeutics' size, closest first, today.

Company	Market cap
TENXTenax Therapeutics	$64.4M
SPROSpero Therapeutics	$64.6M
LFVNLifevantage	$73.4M
ATNMActinium Pharmaceuticals	$47.8M
NATRNatures Sunshine Products	$213.8M
ARVNArvinas	$477.3M
PBYIPuma Biotechnology	$568.9M
IRWDIronwood Pharmaceuticals	$571.7M
ZVRAZevra Therapeutics	$582.6M
CRMDCorMedix	$611.9M
Peer median	$477.3M